SCHEMBL30362452

SCHEMBL30362452

O=C(Nc1cc(C(F)(F)F)ccn1)c1cccc(F)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.62
ALOX15 P16050 1/20 0.62
CASP1 P29466 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62
HSD17B10 Q99714 1/20 0.62
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
GRM5 P41594 1/20 0.59
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
ALDH1A1 P00352 1/20 0.54
PKM P14618 1/20 0.54
PTGS1 P23219 1/20 0.54
BRAF P15056 1/20 0.53
CYP1A2 P05177 1/20 0.52
CYP2C19 P33261 1/20 0.52
MAPT P10636 1/20 0.51
AURKA O14965 2/20 0.51
KCNQ3 O43525 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15904287 1.00 TSHR (0.62) TSHRALOX15CASP1NPSR1HSD17B10
SCHEMBL20016215 0.88 MEN1 (0.58) TSHRALOX15CASP1NPSR1HSD17B10
SCHEMBL1968503 0.86 ALOX15 (0.60) TSHRALOX15CASP1NPSR1HSD17B10
SCHEMBL15903185 0.86 ALOX15 (0.60) TSHRALOX15CASP1NPSR1HSD17B10
SCHEMBL22243546 0.86 ALOX15 (0.60) TSHRALOX15CASP1NPSR1HSD17B10
SCHEMBL30643204 0.86 GRM5 (0.62) TSHRALOX15CASP1NPSR1HSD17B10
SCHEMBL17892572 0.83 CYP1A2 (0.61) TSHRALOX15CASP1NPSR1HSD17B10
SCHEMBL30643210 0.83 CYP1A2 (0.61) TSHRALOX15CASP1NPSR1HSD17B10
SCHEMBL3476295 0.82 TSHR (0.67) TSHRALOX15CASP1NPSR1HSD17B10
Formic Acid SCHEMBL30595912 0.82 ALOX15 (0.55) TSHRALOX15CASP1NPSR1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4006035-B1 QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER NEUPHARMA INC (US) 2023-11-22 EP claimed
CN-109843858-B Certain chemical entities, compositions and methods 润新生物公司 2023-05-05 CN disclosed